{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:05:11Z","timestamp":1788289511310,"version":"build-2803163510"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Obesity and hypertension are among the most prevalent comorbidities in heart failure with preserved ejection fraction (HFpEF). In addition to its relationship with hypertension in HFpEF, obesity is also strongly associated with insulin resistance (IR) and type 2 diabetes (T2D). However, the exact cardiac effects underlying this relationship are unknown. We sought to differentiate the cardiac phenotype associated with increased adiposity in the presence or absence of IR in obese HFpEF. We utilized adipose tissue-specific MitoNEET transgenic mice, which develop chronic, metabolically healthy adipose tissue expansion (obese non\u2013insulin resistant, OB-NIR), and compared them with their wild-type, insulin-resistant littermates (OB-IR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>OB-NIR MitoNEET and OB-IR wildtype mice were fed a high-fat diet for 16 weeks, at which time HFpEF was induced via uninephrectomy, <jats:italic>d<\/jats:italic>-aldosterone infusion, and 1.0% sodium chloride drinking water for 4 additional weeks while maintained on the same diet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>OB-NIR HFpEF mice exhibited reduced cardiac fibrosis without changes in hypertrophy. This reduction was accompanied by increased cardiac expression of SIRT3. Upregulation of several downstream mitochondrial targets of SIRT3 was also observed. These included mitochondrial fission protein 1 (<jats:italic>Fis1<\/jats:italic>), a critical regulator of mitochondrial dynamics, and the antioxidant enzyme heme oxygenase-1 (<jats:italic>Hmox1<\/jats:italic>). In contrast, levels of hydroxy-3-methylglutaryl coenzyme A (CoA) synthase 2 (HMGCS2) were decreased, while both 3-hydroxybutyrate dehydrogenase 1 (<jats:italic>Bdh1<\/jats:italic>) and succinyl-CoA:3-ketoacid CoA transferase (<jats:italic>Oxct1<\/jats:italic>) were elevated. Furthermore, genes involved in the electron transport chain, such as ubiquinol-cytochrome C reductase hinge protein (<jats:italic>Uqcrh<\/jats:italic>, Complex III) and mitochondrially encoded cytochrome c oxidase I (<jats:italic>Mt-Co1<\/jats:italic>, Complex IV), were upregulated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Distinct alterations in cardiac mitochondrial function were observed depending on the presence or absence of IR in obese HFpEF mice. These findings suggest that SIRT3 may play a central role in mediating mitochondrial adaptations in the heart and could represent a promising therapeutic target in HFpEF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1678992","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:30:55Z","timestamp":1758864655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic dysregulation in the heart in obesity-associated HFpEF"],"prefix":"10.3389","volume":"12","author":[{"given":"Maria","family":"Valero-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Leng","family":"Saw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Kusminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bmj.321.7255.215","article-title":"Do patients with suspected heart failure and preserved left ventricular systolic function suffer from \u201cdiastolic heart failure\u201d or from misdiagnosis? A prospective descriptive study","volume":"321","author":"Caruana","year":"2000","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soard.2021.09.009","article-title":"Bariatric surgery decreases the number of future hospital admissions for diastolic heart failure in subjects with severe obesity: a retrospective analysis of the US national inpatient sample database","volume":"18","author":"Romero Funes","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1617","article-title":"Myocardial adipose deposition and the development of heart failure with preserved ejection fraction","volume":"22","author":"Wu","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype: the elephant in the room","volume":"68","author":"Kitzman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jchf.2018.08.007","article-title":"Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic\/obese HFpEF","volume":"6","author":"Kitzman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11897-016-0298-4","article-title":"Cardiometabolic syndrome and increased risk of heart failure","volume":"13","author":"von Bibra","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/nm.2899","article-title":"MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity","volume":"18","author":"Kusminski","year":"2012","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1038\/ncomms4962","article-title":"MitoNEET-mediated effects on browning of white adipose tissue","volume":"5","author":"Kusminski","year":"2014","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e002724","DOI":"10.1161\/CIRCHEARTFAILURE.115.002724","article-title":"Heart failure with preserved ejection fraction induces beiging in adipose tissue","volume":"9","author":"Valero-Munoz","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e008372","DOI":"10.1161\/CIRCHEARTFAILURE.121.008372","article-title":"Endothelial-mesenchymal transition in heart failure with a preserved ejection fraction: insights into the cardiorenal syndrome","volume":"14","author":"Valero-Munoz","year":"2021","journal-title":"Circ Heart Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"966968","DOI":"10.3389\/fcvm.2022.966968","article-title":"Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)","volume":"9","author":"Valero-Munoz","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/HYPERTENSIONAHA.109.134932","article-title":"Effects of fixed-dose isosorbide dinitrate\/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure","volume":"54","author":"Wilson","year":"2009","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1161\/CIRCULATIONAHA.119.043578","article-title":"S-nitrosylation of histone deacetylase 2 by neuronal nitric oxide synthase as a mechanism of diastolic dysfunction","volume":"143","author":"Yoon","year":"2021","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e84897","DOI":"10.1172\/jci.insight.84897","article-title":"Mitochondrial protein hyperacetylation in the failing heart","volume":"2","author":"Horton","year":"2016","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.7150\/thno.45922","article-title":"Mitochondrial sirtuin 3: new emerging biological function and therapeutic target","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2022.01.005","article-title":"Sirtuin 3: emerging therapeutic target for cardiovascular diseases","volume":"180","author":"Cao","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrneph.2017.5","article-title":"Role of NAD(+) and mitochondrial sirtuins in cardiac and renal diseases","volume":"13","author":"Hershberger","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.ddmec.2013.04.001","article-title":"Sirtuin 3: a major control point for obesity-related metabolic diseases?","volume":"10","author":"Newsom","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fphys.2018.01094","article-title":"Acetylation of mitochondrial proteins in the heart: the role of SIRT3","volume":"9","author":"Parodi-Rullan","year":"2018","journal-title":"Front Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jacbts.2020.12.010","article-title":"Understanding HFpEF with obesity: will pigs come to the rescue?","volume":"6","author":"Kass","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.trsl.2014.04.010","article-title":"Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management","volume":"164","author":"Alpert","year":"2014","journal-title":"Transl Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"113904","DOI":"10.1016\/j.addr.2021.113904","article-title":"Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities","volume":"176","author":"Tuleta","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cmet.2019.11.003","article-title":"Disruption of acetyl-lysine turnover in muscle mitochondria promotes insulin resistance and redox stress without overt respiratory dysfunction","volume":"31","author":"Williams","year":"2020","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/cvr\/cvu156","article-title":"Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling","volume":"103","author":"Alrob","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/ars.2018.7632","article-title":"Crosstalk between mitochondrial hyperacetylation and oxidative stress in vascular dysfunction and hypertension","volume":"31","author":"Dikalov","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"B37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/CIRCRESAHA.120.317933","article-title":"Targeting mitochondria-inflammation circuit by beta-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.1302961110","article-title":"Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways","volume":"110","author":"Rardin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.33594\/000000151","article-title":"Mitochondrial hyperacetylation in the failing hearts of obese patients mediated partly by a reduction in SIRT3: the involvement of the mitochondrial permeability transition pore","volume":"53","author":"Castillo","year":"2019","journal-title":"Cell Physiol Biochem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/jcmm.12556","article-title":"High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss","volume":"19","author":"Zeng","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/FJC.0000000000000877","article-title":"SIRT3 ablation deteriorates obesity-related cardiac remodeling by modulating ROS-NF-kappaB-MCP-1 signaling pathway","volume":"76","author":"Guo","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7150\/thno.80289","article-title":"SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells","volume":"13","author":"D'Onofrio","year":"2023","journal-title":"Theranostics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.atherosclerosis.2023.06.971","article-title":"Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque","volume":"378","author":"Marfella","year":"2023","journal-title":"Atherosclerosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1093\/eurheartj\/ehab431","article-title":"PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction","volume":"42","author":"Da Dalt","year":"2021","journal-title":"Eur Heart J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.freeradbiomed.2013.05.002","article-title":"SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage","volume":"63","author":"Tseng","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e85817","DOI":"10.1172\/jci.insight.85817","article-title":"Heme oxygenase-1 regulates mitochondrial quality control in the heart","volume":"1","author":"Hull","year":"2016","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tibs.2015.12.006","article-title":"Mechanisms and dynamics of protein acetylation in mitochondria","volume":"41","author":"Baeza","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yjmcc.2021.12.015","article-title":"Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice","volume":"165","author":"Liu","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","article-title":"Ketones and the heart: metabolic principles and therapeutic implications","volume":"132","author":"Matsuura","year":"2023","journal-title":"Circ Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jchf.2023.05.009","article-title":"Ketogenic diet in heart failure: fact or fiction?","volume":"11","author":"Kodur","year":"2023","journal-title":"JACC Heart Fail"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.2147\/JIR.S331320","article-title":"Beta-hydroxybutyrate mitigated heart failure with preserved ejection fraction by increasing treg cells via Nox2\/GSK-3beta","volume":"14","author":"Liao","year":"2021","journal-title":"J Inflamm Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.jacc.2019.01.056","article-title":"Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics","volume":"73","author":"Santos-Gallego","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes"},{"key":"B56","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","article-title":"SIRT3 deficiency impairs mitochondrial and contractile function in the heart","volume":"110","author":"Koentges","year":"2015","journal-title":"Basic Res Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1678992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:30:56Z","timestamp":1758864656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1678992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":57,"alternative-id":["10.3389\/fcvm.2025.1678992"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1678992","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"article-number":"1678992"}}